Gemina Laboratories OTC Stock Top Insiders

GLABF Stock  USD 0.55  0.01  1.79%   
Gemina Laboratories employs about 5 people. The company is managed by 4 executives with a total tenure of roughly 12 years, averaging almost 3.0 years of service per executive, having 1.25 employees per reported executive. Examination of Gemina Laboratories' management performance can provide insight into the company performance.
David Browning  Insider
Head Limited
Brian Firth  Insider
Chief Officer
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gemina Laboratories. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Gemina Laboratories Management Team Effectiveness

The company has return on total asset (ROA) of (1.4765) % which means that it has lost $1.4765 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (3.4671) %, meaning that it generated substantial loss on money invested by shareholders. Gemina Laboratories' management efficiency ratios could be used to measure how well Gemina Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.

Gemina Laboratories Workforce Comparison

Gemina Laboratories is rated # 2 in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 99,668. Gemina Laboratories adds roughly 5.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.

Gemina Laboratories Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Gemina Laboratories Price Series Summation is a cross summation of Gemina Laboratories price series and its benchmark/peer.

Gemina Laboratories Notable Stakeholders

A Gemina Laboratories stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Gemina Laboratories often face trade-offs trying to please all of them. Gemina Laboratories' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Gemina Laboratories' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About Gemina Laboratories Management Performance

The success or failure of an entity such as Gemina Laboratories often depends on how effective the management is. Gemina Laboratories management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Gemina management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Gemina management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. It is developing POC Antigen COVID test, a point-of-care lateral flow assay test strip to test whether or not a person is currently infected with COVID-19. Gemina Laboratories operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 5 people.
The data published in Gemina Laboratories' official financial statements typically reflect Gemina Laboratories' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Gemina Laboratories' quantitative information. For example, before you start analyzing numbers published by Gemina accountants, it's essential to understand Gemina Laboratories' liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.

Gemina Laboratories Workforce Analysis

Traditionally, organizations such as Gemina Laboratories use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Gemina Laboratories within its industry.

Gemina Laboratories Manpower Efficiency

Return on Gemina Laboratories Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee947K
Net Loss Per Executive1.2M

Complementary Tools for Gemina OTC Stock analysis

When running Gemina Laboratories' price analysis, check to measure Gemina Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gemina Laboratories is operating at the current time. Most of Gemina Laboratories' value examination focuses on studying past and present price action to predict the probability of Gemina Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gemina Laboratories' price. Additionally, you may evaluate how the addition of Gemina Laboratories to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Valuation
Check real value of public entities based on technical and fundamental data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum